CSF biomarker variability in the Alzheimer's Association quality control program
Niklas Mattsson(Malmö University), Olivier Bousiges(Centre National de la Recherche Scientifique), Sergio Bernardini(University of Rome Tor Vergata), Marcel M. Verbeek(Radboud University Nijmegen), Staffan Persson(University of Copenhagen), Alberto Lleó(Hospital de Sant Pau), Manu Vandijck(Fujirebio (Belgium)), Robert A. Rissman(University of Southern California), Aurélie Bedel(Université de Bordeaux), John Q. Trojanowski(University of Pennsylvania), Piero Parchi(Istituto delle Scienze Neurologiche di Bologna), Kaj Blennow(Sahlgrenska University Hospital), Anne M. Fagan(Washington University in St. Louis), María C. Carrillo(Brigham and Women's Hospital), Sonia Chalbot(New York State Office for People With Developmental Disabilities), Diane Dufour‐Rainfray(Université de Tours), Giuseppe Sancesario(University of Rome Tor Vergata), Steven Collins(Florey Institute of Neuroscience and Mental Health), Aladro José A. Rojo(Alzheimer's Association), José Luís Molinuevo(Pasqual Maragall Foundation), Hugo Vanderstichele(ADx NeuroSciences), Piotr Lewczuk(Universitätsklinikum Erlangen), Stephan A. Käser(Alzheimer's Association), Ulf Andréasson(Sahlgrenska University Hospital), Ging‐Yuek Robin Hsiung(University of British Columbia), Marinus A. Blankenstein(Amsterdam UMC Location Vrije Universiteit Amsterdam), Bradley T. Hyman(Harvard University), Charlotte E. Teunissen(Amsterdam Neuroscience), Axel Regeniter(Alzheimer's Association), Aleš Bartoš(Charles University), Danièle Bentué‐Ferrer(Alzheimer's Association), Henrik Zetterberg(University of Wisconsin–Madison), Flora Berisha(Janssen (United States)), Inês Baldeiras(University of Coimbra), Eva Lagberg Arkblad(Alzheimer's Association), Daniel Alcolea(Hospital de Sant Pau), D. Richard Lachno(Alzheimer's Association), Dev Batish(Alzheimer's Association), Leslie M. Shaw(California University of Pennsylvania), Hiroyuki Arai(Tohoku University), Khalid Iqbal(Alzheimer's Association), Silvana Archetti(University of Brescia), Niels H. H. Heegaard(Statens Serum Institut), Anna Antonell(Alzheimer's Association), Neal E. Cutler(Worldwide Clinical Trials (United States)), Johannes Schröder(Heidelberg University), Marilyn Albert(Johns Hopkins Medicine), Hanna Rosenmann(AHEPA University Hospital)
Cited by 386
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
|NeuroImage|2006|14.1k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k